News-2 - StoneWise AI

Latest News

Collaboration | StoneWise Partners with Chipscreen Biosciences to Build an End-to-End AI-Powered Paradigm for Early-Stage Drug Discovery

2025-11-19
Collaboration｜StoneWise Presents AI-Powered Small Molecule R&D Technology at TEDA Seminar, Jointly Promoting High-Quality Industrial Development

2025-11-12
StoneWise Selected into Frost & Sullivan's AI4LS Blue Paper, Technological Strength Recognized by Industry Authority!

2025-11-04
From Technological Breakthrough to Industrial Innovation: StoneWise's MolVado Small-Molecule Drug Design Platform Debuts at HUAWEI CONNECT 2025, Defining a New Height in AI-Powered Drug Discovery

2025-09-24
AI Reconstructs Drug Discovery The Transformation from Theoretical Breakthrough to Clinical Value [July 9th AI Half-Month Talk] Grand Launch

2025-07-09
Stonewise Debuts at AIBC2025, Focusing on Two Core Challenges of Molecular Generation Models Data and Evaluation

2025-06-18

Total of 11 entries, total of 2 pages

Academic progress

Total of 22 entries, total of 4 pages

Start Your Intelligent Drug Design Journey

MolVado Small Molecule Drug Design Platform – Empowering Your R&D Breakthroughs

产品&服务

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai